AITB Insider Trading Activity and SEC Form 4 Filings
AITB insider trading summary
No open-market insider purchases or sales of AIT Therapeutics, Inc. (AITB) have been reported on SEC Form 4 in the past 12 months.
Latest AITB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 22, 2018 | Ari Raved | Director | Sell | $237K (74,000 @ $3.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.